Xeris Biopharma Holdings, Inc.

Q2 2026 13F Holders

Symbol
XERS
CUSIP
98422E103
Type
Equity
Class
COM
Num filings
252
Total reported value, excl. options
$1.04 B
Manager Report Date Value ($000) Shares Option Type